1-18 of 18
Liping Su
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2023-174308
Published: 2023
Journal Articles

Phase 2 Study of Golidocitinib, a JAK1 Selective Inhibitor, As Maintenance Therapy in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy (JACKPOT26)

Jie Jin, Qingqing Cai, Liling Zhang, Liqun Zou, Zengjun Li, Huijing Wu, Keshu Zhou, Lihua Qiu, Liping Su, Kaiyang Ding, Hui Zhou, Li Yu, Fei Li, Qing Xiao, Wenyu Li, Lie Lin, Erhua Wang, Lijia Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4430.
https://doi.org/10.1182/blood-2023-185543
Published: 2023
Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Huixing Zhou, Long Chang, Jing Jia, Jie Ma, Hua Xue, Hao Li, Wenrong Huang, Hebing Zhou, Jingnan Sun, Liping Su, Yanping Ma, Huang Hongming, Hongmei Jing, Zhenling Li, Guangyu Ma, Guohong Su, Jihao Zhou, Biyun Chen, LI Bao, Zhihua Zhang, Lin Yang, Haiping Yang, Yanhong Zhao, Chunyan Sun, Qingming Wang, Qimuge Saiyin, Da Gao, Xiaoxia Chu, Zhenfang Xi, Weiwei Tian, Xuliang Shen, Shi Minxia, Jin Zhang, Yi Chen, Jingbo Xu, Yao Liu, Hongling Peng, Weijun Fu, Jun Luo, Zhenyu Li, Hui-Han Wang, Xiaobo Wang, Xiuli Sun, Jinqiao Zhang, Wei WANG, Yan Yan, Yafei Wang, Xin Du, Yonghuai Feng, Yi Wang, Ying Sun, Liye Zhong, Li Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2023) 142 (Supplement 1): 4754.
https://doi.org/10.1182/blood-2023-180736
Published: 2023
Journal Articles

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Jie Zha, Qinwei Chen, Wei Zhang, Hongmei Jing, Jingjing Ye, Haifeng Yu, Shuhua Yi, Caixia Li, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2023-182812
Published: 2023
Journal Articles

A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses

Huilai Zhang, Liping Su, Lihong Liu, Ou Bai, Zheng Song, Zhiqiang Zhao, Cuiying He, Qiang Guo, Xianhuo Wang, Wei Li, Lihua Qiu, Lanfang Li, Shiyong Zhou, Yue Fei, Xiaohui Wang, Bin Meng
Journal: Blood
Blood (2023) 142 (Supplement 1): 736.
https://doi.org/10.1182/blood-2023-178509
Published: 2023
Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Ying Wang, Zhenling Li, Zhijuan Lin, Yun Cai, Tiejun Gong, Wei Yang, Siting Xie, Zhenqi Huang, Pengcheng SHI, Lin Fu, Jinghua Wang, Xiangjun Fu, Xianqi Feng, Liping Su, Jianmin Luo, Lin Yang, Biyun Chen, Ying Xie, Yu Zhu, Xin Du, Yirong Jiang, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4274.
https://doi.org/10.1182/blood-2023-182832
Published: 2023
Journal Articles

Renal Response of Pomalidomide with Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Yuan Jian, Long Chang, Mingxia Shi, Ying Sun, Xiaoxia Chu, Hua Xue, Wenrong Huang, Xuliang Shen, Jie Ma, Guorong Jia, Yaqing Feng, Zhenfang Xi, Yanhong Zhao, Yanping Ma, Jing Xiao, Guangyu Ma, Qingming Wang, Li Bao, Yujun Dong, Hebing Zhou, Chunyan Sun, Guohong Su, Yan Yan, Saiyin Qimuge, Liping Su, Jingnan Sun, Weiwei Tian, Xiuli Sun, Hongmei Jing, Da Gao, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2022) 140 (Supplement 1): 10167–10169.
https://doi.org/10.1182/blood-2022-159361
Published: 2022
Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Hui Zhou, Mengya Zhong, Ying Wang, Xin Du, Tiejun Gong, Zhijuan Lin, Yun Cai, Siting Xie, Chendi Xie, XianQi Feng, ZhenQi Huang, Liping Su, Jianmin Luo, Lin Yang, Zhenling Li, Bi-yun Chen, Ying Xie, Yu Zhu, Pengcheng Shi, Zhifeng Li, Yirong Jiang, Bing Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3292–3293.
https://doi.org/10.1182/blood-2022-165261
Published: 2022
Journal Articles

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Lu Zhang, Yujun Dong, Hongling Peng, Hao Li, Mingzhi Zhang, Hui-Han Wang, Qinhua Liu, Liping Su, Liye Zhong, Wenjun Wu, Liang Huang, Xiaojing Yan, Lei Fan, Wenjiao Tang, Zhenling Li, Lintao Bi, Yan Li, Guangxun Gao, Li Gao, Ting-Bo Liu, Yongqiang Wei, Yao Liu, Yu Li, Hui Zhou, Chunyan Sun, Wenbin Qian, Dehui Zou, Huilai Zhang, Kaiyang Ding, Xiaobo Wang, Ou Bai, Wenrong Huang, Bing Chen, Lin Yang, Jia Song, Da Gao, Tong Chen, Jun Luo, Shuye Wang, Liangming Ma, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 3609–3611.
https://doi.org/10.1182/blood-2022-158675
Published: 2022
Journal Articles

Efficacy and Survival in Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized, Controlled, Multicenter and Open-Labled Study with Ddgp Regimen Versus SMILE Regimen

Xinhua Wang, MD PhD, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhiyuan Zhou, Xiaolong Wu, Li Tian, Wencai Li, Hongwei Xue, Jinghua Wang, Liqun Zou, Liping Su, Yi Lu, Yanzhen Guo, Ken H. Young, Mingzhi Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 463.
https://doi.org/10.1182/blood-2019-127811
Published: 2019
Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1569.
https://doi.org/10.1182/blood-2019-123478
Published: 2019
Journal Articles

Combination of Chidamide with the CHOEP Regimen in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial

Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuqin Song, Huilai Zhang, MD, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, Owen A. O'Connor, Daobin Zhou
Journal: Blood
Blood (2019) 134 (Supplement_1): 4036.
https://doi.org/10.1182/blood-2019-129305
Published: 2019
Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5167.
https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167
Published: 2017
Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xuenong Ouyang, Xiaolin Li, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5213.
https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213
Published: 2017
Journal Articles

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2017) 130 (Supplement 1): 5208.
https://doi.org/10.1182/blood.V130.Suppl_1.5208.5208
Published: 2017
Journal Articles

Pegaspargase Plus Gemcitabine, Oxaliplatin(P-Gemox) and Thalidomide Versus Aspermetdex Regimen for the Patients with Early or Advanced/Relapsed Extranodal Natural Killer/T Cell Lymphoma: Interim Analysis of a Prospective,Multicenter, Randomized, Phase III Non-Inferiority Clinical Trial

Yan Gao, Huiqiang Huang, MD, Yujing Zhang, Hang Su, Xiaoxiao Wang, Bing Bai, Yunhong Huang, Yuhuan Gao, Liping Su, MD, Xiaoxia Chu, Wenyu Li, Junyi Zhang, Qiaohua Zhang, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1819.
https://doi.org/10.1182/blood.V128.22.1819.1819
Published: 2016
Journal Articles

Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)

Shaoxuan Hu, MD, Yuqin Song, MD, Yufu Li, MD, Xiuhua Sun, MD, Liping Su, MD, Wei Zhang, MD, Jing Jia, MD, Ou Bai, MD, Rong Liang, MD, Xiaoling Li, MD, Huilai Zhang, MD, Yuhuan Gao, MD, Weijing Zhang, MD, Xiubin Xiao, MD, Huizheng Bao, MD, Ningju Wang, MD, Hanyun Ren, MD, Xinan Cen, MD, Shun'e Yang, MD, Yu Zhao, MD, Yinan Wang, MD, Yalan Wang, MD, Aichun Liu, MD, Jingwen Wang, MD, Yuankai Shi, MD, Ming Yuan, Xiaohui He, MD
Journal: Blood
Blood (2016) 128 (22): 4228.
https://doi.org/10.1182/blood.V128.22.4228.4228
Published: 2016
Journal Articles

A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, MD, Jianqiu Wu, MD, Yongping Song, Liping Su, Mingzhi Zhang, MD, Wei Li, Yu Hu, Xiaohong Zhang, MD, Yuhuan Gao, Ru Feng, MD, Wei Wang, MD, Zuoxing Niu, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changing Wu, Weijing Zhang, MD, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, Zimin Sun, PharmD, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2014) 124 (21): 5475.
https://doi.org/10.1182/blood.V124.21.5475.5475
Published: 2014